# A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

> **NCT06671496** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 600 (estimated)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Zasocitinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06671496
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2027-05-18
- **Final completion:** 2028-01-26
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671496, "A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06671496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*